Physician

Brooke Nesmith, MD

According to 2025 Medicare claims, Brooke Nesmith, MD (NPI: 1295020667) practices ophthalmology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS & SURGEONS PA (NPI: 1275557761; TIN: 48-0817150) and primary practice location at 67214-4837.

Nesmith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,083 traditional Medicare patients, billed 76,235 HCPCS/CPT codes, and received $4,173,689 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 366 prescription claims across 133 beneficiaries totaling $9,315 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,322 to $4,173,689. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,616 and ending at $9,315. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2016 Medicare payment: $4,322 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $196,284 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,055,123 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,267,787 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,752,149 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,660,331 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,613,977 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,823,979 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,173,689 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201690102$4,322
20173321,552$196,284
20188518,039$1,055,123
20191,05413,011$2,267,787
20201,05113,044$2,752,149
20211,12115,256$3,660,331
20221,07614,456$3,613,977
20231,03335,072$3,823,979
20241,08376,235$4,173,689

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.8K$16K2015 Drug cost: $6,616 (USD; Tot_Drug_Cst)2016 Drug cost: $15,032 (USD; Tot_Drug_Cst)2017 Drug cost: $12,157 (USD; Tot_Drug_Cst)2018 Drug cost: $15,629 (USD; Tot_Drug_Cst)2019 Drug cost: $11,743 (USD; Tot_Drug_Cst)2020 Drug cost: $11,660 (USD; Tot_Drug_Cst)2021 Drug cost: $13,138 (USD; Tot_Drug_Cst)2022 Drug cost: $7,774 (USD; Tot_Drug_Cst)2023 Drug cost: $9,778 (USD; Tot_Drug_Cst)2024 Drug cost: $9,315 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201554148$6,616
201689254$15,032
201772202$12,157
201897244$15,629
2019101230$11,743
202099253$11,660
2021113236$13,138
2022100225$7,774
2023115270$9,778
2024133366$9,315

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2312,320$655
67028Injection of drug into eye6122,417$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more518763$59
J2777Injection, faricimab-svoa, 0.1 mg21763,000$27
92134Imaging of retina9373,012$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1193,170$3,264
OfloxacinOfloxacin721,519$818
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat292,300$516
LatanoprostLatanoprost371,899$241
Dorzolamide HclDorzolamide Hcl14795$160

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$95Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$28,668US Retina LLC

FAQ

What Medicare data is available for Brooke Nesmith, MD?

Tedicare shows public-source Medicare data for Brooke Nesmith, MD (NPI 1295020667), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brooke Nesmith, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brooke Nesmith, MD?

Brooke Nesmith, MD is linked to VITREO-RETINAL CONSULTANTS & SURGEONS PA (billing NPI 1275557761) in the available physician profile data.

Does Brooke Nesmith, MD have Open Payments data?

Brooke Nesmith, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.